Breaking News Headlines Today

News about Amgen

Stay current with all the latest and breaking news about Amgen, compare headlines and perspectives between news sources on stories happening today. In total, 101 stories have been published about Amgen which Ground News has aggregated in the past 3 months.

Covered Most By

Sportskeeda

Center

Irish Golfer News & Magazine

Local News Publishers

Suggest a source

Looking for a source we don't already have? Suggest one here.

Top Amgen News

Ireland Politics · Doonbeg

Trump Doonbeg to Host Irish Open in 2026

45% Center coverage: 27 sources

The Trump International Golf Club in Doonbeg will host next year's Amgen Irish Open.The DP World Tour schedule for the 2026-2027 was announced today, confirming the Co Clare links - owned by US President Donald Trump - will stage the tournament for the first time, from 10-13 September 2026.See the Story

Amgen · Thousand Oaks

Amgen Rocatinlimab's Data Shows Potential As Long-Term Therapy For Atopic Dermatitis - Amgen (NASDAQ:AMGN)

84% Center coverage: 13 sources

Amgen Inc. (NASDAQ:AMGN) and Kyowa Kirin released preliminary topline results from the ASCEND study evaluating rocatinlimab in adults and adolescents with moderate to severe atopic dermatitis (AD) on Tuesday. The ongoing ASCEND study, which includes approximately 2,600 patients, is designed to evaluate the long-term safety and efficacy of rocatinlimab (150 mg and 300 mg) administered every four or eight weeks in individuals who completed a previ…See the Story

Amgen

Ollin debuts with $100M and plans to challenge top-selling eye drugs

100% Center coverage: 1 sources

Backed by a trio of top venture firms, Ollin is working on a pair of medicines it believes can one-up Roche’s Vabysmo and Amgen’s Tepezza.See the Story

‘I fell in love with Dublin’s international atmosphere ... so I decided to stay and build my career in Ireland’

100% Left coverage: 1 sources

Leire Asua (Accenture) and Hamed Benyounis (Amgen)Amgen · Dublin Read Article

Ollin debuts with $100M and plans to challenge top-selling eye drugs

100% Center coverage: 1 sources

Backed by a trio of top venture firms, Ollin is working on a pair of medicines it believes can one-up Roche’s Vabysmo and Amgen’s Tepezza.Amgen See the Story

Livforsakringsbolaget Skandia Omsesidigt Increases Stock Position in Booking Holdings Inc. $BKNG

Livforsakringsbolaget Skandia Omsesidigt lifted its holdings in shares of Booking Holdings Inc. (NASDAQ:BKNG – Free Report) by 242.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,189 shares of the business services provider’s stock after buying an additional 5,795 shares during the […]Amgen · Sweden See the Story

Global Biotech Leaders Amgen and Gilead Announcing Expansions in California, the #1 State for Life Sciences

SAN FRANCISCO — Governor Gavin Newsom today highlighted major expansions from Amgen and Gilead Sciences that will bring nearly $1.5 billion in investment, thousands of new jobs and continued momentum to California’s biotech sector. These projects strengthen California’s position as a global leader in life sciences, research and innovation.“California has long been a global leader in life sciences innovation, powered by a skilled workforce that c…Gavin Newsom · California See the Story

Over €170,000 raised for Make-A-Wish Ireland at the Amgen Irish Open - Irish Golfer Magazine

Over €170,000 has been raised for Make-A-Wish Ireland at the 2025 Amgen Irish Open with more than €80,000 of that amount coming from the Birdies for Wishes initiative on the 18th hole. Make-A-Wish Ireland was the official Charity Partner for the fourth consecutive year at the tournament, with the aim of raising funds to grant wishes to children living with life-threatening medical conditions. The Birdies for Wishes campaign was one of several fu…Amgen · Kildare See the Story

Amgen Rocatinlimab's Data Shows Potential As Long-Term Therapy For Atopic Dermatitis - Amgen (NASDAQ:AMGN)

84% Center coverage: 13 sources

News about Amgen

News about Amgen

Covered Most By

Local News Publishers

Top Amgen News

Trump Doonbeg to Host Irish Open in 2026

Amgen Rocatinlimab's Data Shows Potential As Long-Term Therapy For Atopic Dermatitis - Amgen (NASDAQ:AMGN)

Ollin debuts with $100M and plans to challenge top-selling eye drugs

‘I fell in love with Dublin’s international atmosphere ... so I decided to stay and build my career in Ireland’

Ollin debuts with $100M and plans to challenge top-selling eye drugs

Livforsakringsbolaget Skandia Omsesidigt Increases Stock Position in Booking Holdings Inc. $BKNG

Global Biotech Leaders Amgen and Gilead Announcing Expansions in California, the #1 State for Life Sciences

Amgen investing $600 million in Thousand Oaks headquarters expansion

Samsung Biologics, Amgen and Biocon invest in US pharma sites

Psoriasis in Minors with Otezla (Amgen): Doubts in Efficacy and Weight Loss

Trump Doonbeg to Host Irish Open in 2026

Over €170,000 raised for Make-A-Wish Ireland at the Amgen Irish Open - Irish Golfer Magazine

Amgen Rocatinlimab's Data Shows Potential As Long-Term Therapy For Atopic Dermatitis - Amgen (NASDAQ:AMGN)

Covered Most By

Media Bias Breakdown

Breaking News Topics Related to Amgen

‘I fell in love with Dublin’s international atmosphere ... so I decided to stay and build my career in Ireland’

Ollin debuts with $100M and plans to challenge top-selling eye drugs

Livforsakringsbolaget Skandia Omsesidigt Increases Stock Position in Booking Holdings Inc. $BKNG

Global Biotech Leaders Amgen and Gilead Announcing Expansions in California, the #1 State for Life Sciences

Amgen investing $600 million in Thousand Oaks headquarters expansion

Samsung Biologics, Amgen and Biocon invest in US pharma sites

Psoriasis in Minors with Otezla (Amgen): Doubts in Efficacy and Weight Loss

Trump Doonbeg to Host Irish Open in 2026

Over €170,000 raised for Make-A-Wish Ireland at the Amgen Irish Open - Irish Golfer Magazine

Amgen Rocatinlimab's Data Shows Potential As Long-Term Therapy For Atopic Dermatitis - Amgen (NASDAQ:AMGN)